Optimizerx Corporation ( (OPRX) ) has released its Q4 earnings. Here is a breakdown of the information Optimizerx Corporation presented to its investors.
OptimizeRx Corporation is a healthcare technology company that provides innovative solutions to connect life sciences brands with healthcare professionals and patients, focusing on improving patient outcomes and brand visibility in the digital healthcare environment. In its latest earnings report, OptimizeRx announced a strong performance for the fourth quarter and full year of 2024, with a notable increase in revenue and gross profit. The company reported a 14% year-over-year increase in fourth-quarter revenue, reaching $32.3 million, and a 23% rise in gross profit to $22.0 million. For the full year, revenue grew by 29% to $92.1 million, while gross profit increased to $59.4 million. The company also highlighted a significant increase in DAAP deals, doubling from 24 in 2023 to 48 in 2024, and improved net revenue retention of 121%. Despite a GAAP net loss for the year, OptimizeRx achieved a non-GAAP net income of $6.2 million and an adjusted EBITDA of $11.7 million, reflecting a 53% increase in the fourth quarter. Looking ahead, OptimizeRx is optimistic about its growth prospects for 2025, with expectations of at least $100 million in revenue and an adjusted EBITDA of at least $12 million. The company plans to focus on operational excellence, customer-centric strategies, and transitioning to a subscription-based model to enhance profitability and shareholder value.